|
|
|
Erythroblastosis fetalis |
| Definition: |
|
Erythroblastosis fetalis is a severe anemia that develops in an unborn infant because the mother produces antibodies that attack the fetus' red blood cells. The antibodies are usually caused by Rh incompatibility between the mother’s blood type and that of the fetus (that is, the mother and baby have different blood types). The severity of this condition can vary widely. In some instances this can lead to death of the baby. It can be treated in utero (before birth) by medication or intrauterine transfusion. When the child is born, signs may include an enlarged liver and/or spleen, generalized edema (swelling, anasarca), jaundice, and anemia. After birth, depending on the severity, a transfusion may be performed. See also Transfusion reaction. |
| Alternative Names: |
| Hemolytic disease of the newborn due to Rh incompatibility |
Reviewed By:
 |
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
